Infera (YC X26) — Control lab instruments with natural language
Describe an experiment in plain English, and Infera turns it into a validated, instrument-ready run across the equipment your lab already uses. Infera handles the protocol logic, vendor-specific scripts, data, inventory, and institutional knowledge in one system.
Sell to companies like these? Paste your website and see 10 with a filed reason to buy this month. Free.
Opens in a new tab. No signup.
What it does Control lab instruments with natural language (source)
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
Describe an experiment in plain English, and Infera turns it into a validated, instrument-ready run across the equipment your lab already uses. Infera handles the protocol logic, vendor-specific scripts, data, inventory, and institutional knowledge in one system. An AI-native compiler for the lab: one system from intent to execution.
What the site is built with
Next.jsframeworkVercelhosting
Read from the page's own HTML and response headers on 10 September 2026, at https://www.infera.bio/. Each badge matched a string the site serves about itself — hover one to see which. Nothing here is a traffic, ranking or revenue figure: those cannot be read off a page and are not claimed.
Checked away from the directory entry. Neither line below comes from the company's Y Combinator page.
Infera is the operating system for your laboratory. Protocol validation, experiment preview, lab ordering, data analysis. End-to-end.
The title and description the site itself served, answering 200. Not a cached copy and not the company's directory entry — what was live when we asked.
Counted only where a thread links to this company's own site, announces it by name on that forum, or names it beside its own Y Combinator batch. A thread whose title merely carries the words is not counted — a name is not an identifier. Hacker News is not us, and nothing above is our opinion of the company.
Troy Zhang
Founder/CEO
Founder at Infera. R. H. Cox Research Fellow in Nobel Prize winning lab. Dual BS in Political Science and Computation and Neural Systems from Caltech.
Chloe Sow
Founder/CTO
Co-Founder of Infera (YC P26). Built research software and medical devices at Harvard Medical School, Brigham and Women's, Fred Hutch and PNNL. MechE + CS at Harvard.
Founders, titles and bios as the company published them. Photographs are our own copies of the ones on that record, so they do not break when the original link expires.
One of 34 companies held here in Healthcare › Industrial Bio.
No investor is drawn from a Form D — the form states how many invested and never who. The one investor on this graph is named because a batch has exactly one.
Want the whole picture on Infera?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Infera: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Infera covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
8 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
You get an alert in MentionFox the next time this company shows up.
Is this you?
If you're behind Infera: acceptance into a YC batch is one of the few weeks a young company gets looked up by people who matter — investors, other founders, press. FoxPlug turns the commits, deploys, and releases you're already making into that story automatically, so anyone who looks finds something current. GetFoxChat puts a guide on your own site so the people YC's own page just sent you don't read one line and leave.
